Rankings
▼
Calendar
PMVP Q4 2022 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$88M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$21M
Net Income
-$19M
EPS (Diluted)
$-0.42
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$17M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$270M
Total Liabilities
$24M
Stockholders' Equity
$246M
Cash & Equivalents
$108M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$21M
-$18M
-14.6%
Net Income
-$19M
-$18M
-5.4%
← FY 2022
All Quarters
Q1 2023 →